Clinical trial
A Study Evaluating Efficacy and Safety of Ceftriaxone Sodium and Sulbactam Sodium for Injection in the Treatment of Uncomplicated Urogenital Gonorrhea
NCT04202068 is registered in ClinicalTrials.gov with Xiangbei Welman Pharmaceutical Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study Evaluating Efficacy and Safety of Ceftriaxone Sodium and Sulbactam Sodium for Injection in the Treatment of Uncomplicated Urogenital Gonorrhea
- Lead sponsor
- Xiangbei Welman Pharmaceutical Co., Ltd
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 3, 2015
- Completion date
- May 30, 2016
- Enrollment
- 113 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.